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Clostridium tertium Bacteremia in a Non-neutropenic 
Patient with Small Bowel Obstruction
Clostridium tertium-induced bacteremia is a rare condition seen predominantly in 
neutropenic patients and/or patients with gastrointestinal disease. In this report, we 
describe a non-neutropenic, 72-year-old patient with a small bowel obstruction 
who presented with C. tertium bacteremia. Clostridium tertium is aerotolerant and 
resistant to broad-spectrum cephalosporins. The aerotolerant nature of C. tertium is 
resulted in delayed identification and reporting since it is not initially considered a 
candidate for infection.
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Introduction
The genus Clostridium is a diverse group of Gram-positive, spore-forming, 
anaerobic bacilli found in soil and the guts of many animals, including humans. 
Clostridium-induced bacteremia is a rare condition seen primarily in intra-
abdominal infections associated with surgical trauma. It has also been associated 
with underlying gastrointestinal disorders, pregnancy, and malignancies [1].
Clostridium tertium was not recognized as a human pathogen until 1963 [2]. 
It is most frequently isolated from blood cultures, although it can also cause 
spontaneous bacterial peritonitis, brain abscesses, and pneumonia [3-5]. 
Most cases of C. tertium-induced bacteremia occur in neutropenic patients 
without a definite source of infection [3, 5]. Here, we describe a case of C. 
tertium bacteremia in a 72-year-old non-neutropenic patient with an intestinal 
obstruction.
Case report
A 72-year-old male was admitted with diffuse abdominal pain, which had 
started four days earlier. He had a history of colon cancer, diagnosed in 1998, 
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and had been treated with a left hemicolectomy. Two years prior 
to admission, he was diagnosed with a hepatocellular carcinoma 
(B-viral) and had undergone five rounds of transcatheter arterial 
chemoembolization. Upon admission, his body temperature 
was 38.3°C, his heart rate was 93 beats per minute, his respiratory 
rate was 20 per min, and his blood pressure was 123/75 mmHg. 
Physical examination revealed increased bowel sounds and direct/
rebound tenderness on the entire abdomen. His initial white blood 
cell count was 8,320/mm3 (86.5% neutrophils), his hemoglobin 
level was 12.6 g/dL, his platelet count was 6,800/mm3, and his 
C-reactive protein level was 246 mg/L. Abdominal CT revealed 
fluid-filled, dilated small bowel loops, most likely at the proximal 
ileum (Fig. 1).
With a preliminary diagnosis of small bowel obstruction, a 
nasogastric tube was inserted for decompression. Intravenous 
antibiotic therapy was initiated with piperacillin-tazobactam 
(4.5 g every 8 h). However, the small bowel obstruction did not 
improve with intravenous antibiotic therapy and supportive care. 
The patient had a persistent fever and severe abdominal pain. His 
blood leukocytes were also elevated (16,650/µL). These clinical 
findings, combined with a subsequent plain radiograph, led to 
suspicion of strangulation (Fig. 2).
On the fifth day after admission, laparotomy and segmental 
resection of the small bowel with end ileostomy were performed 
to confirm the strangulation. Tigecycline (50 mg every 12 h after 
an initial 100 mg dose) was administered intravenously due to a 
persistent fever, despite the use of piperacillin-tazobactam. On the 
seventh day after admission, a blood culture revealed C. tertium.
Upon admission, three sets of aerobic and anaerobic blood 
cultures were set up using the BacT/Alert 3D system (bioMérieux, 
Durham, NC, USA). The two anaerobic bottles yielded bacterial 
growth on the first day of incubation, while the corresponding 
aerobic bottles revealed growth three days later. Staining showed 
Gram-variable bacilli lacking spores. Sub-culturing from all of the 
Figure 1. Abdominal computed tomography (CT) at admission shows fluid-filled, dilated small bowel loops 
at the proximal ileum. An adhesion band is a possible cause of the obstruction (red arrows).
Figure 2. The simple plain X-ray on the fifth day after admission shows distended small bowel loops with 
air fluid level.
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positive bottles yielded colonies, but those on anaerobic plates 
were larger, suggesting that the organism was aerotolerant. Gram 
staining of the colonies from the anaerobic subculture revealed 
occasional terminal spores (Fig. 3). Bacterial identification using 
both the Rapid ID 32A system and ANI card (bioMérieux, Marcy l’
Étoile, France) revealed C. tertium. The strain was confirmed by 
PCR and nucleotide sequencing of the bacterial 16S rRNA gene. 
The sequences were compared with known sequences in the 
EzTaxon server database (http://www.eztaxon.org; accessed 
2 Mar 2011), which revealed 100% homology with C. tertium 
(GenBank accession number Y18174.1).
Three days post-operation, intra-abdominal bleeding was 
observed, and oliguric acute renal failure developed. Explorative 
laparotomy revealed active bleeding from the inferior epigastric 
artery in the left rectus muscle, and suture ligation was performed. 
In the presence of tigecycline, the same organism was observed 
at follow-up blood cultures on days 6 and 8, but not on day 13. The 
patient gradually deteriorated despite aggressive treatment and 
eventually died 19 days after admission due to multi-organ failure 
and acute respiratory distress syndrome.
Discussion
Clostridium tertium bacteremia is a rare condition mainly as-
sociated with neutropenia in critically ill patients [6-8]. Miller et 
al. [3] reported that 91% (29/32) of cases of C. tertium-related 
bacteremia occurred in neutropenic patients. Several other 
studies have also reported neutropenia as a major factor in C. 
tertium bacteremia [6, 8-12]. The exact role of neutropenia in the 
pathogenesis of C. tertium is unclear. However, it may enable C. 
tertium to enter the systemic circulation and facilitate the organism’
s growth by dampening the innate immune response [3].
In non-neutropenic patients, C. tertium bacteremia is associated 
with intestinal abnormalities. Three distinct cases of C. tertium 
bacteremia in non-neutropenic patients have been described [3]. 
Of these, one had severe liver disease and spontaneous bacterial 
peritonitis, one recently had a percutaneous gastrostomy tube 
implanted, and one had Crohn’s disease [3]. A case of C. tertium 
bacteremia in non-neutropenic post-operative patients with a 
mechanical ileus has also been reported [13]. Clostridium tertium 
bacteremia in non-neutropenic patients is promoted by various 
abdominal disorders (e.g., chronic inflammatory bowel disease), 
as well as by the administration of anti-cancer drugs [7, 9]. In the 
current case, the patient was non-neutropenic but had a small 
bowel obstruction with strangulation. The obstruction damaged 
the intestinal mucosa, allowing C. tertium to enter the systemic 
circulation.
Clostridium tertium is not significantly pathogenic, and some 
authors claim that C. tertium is not a true pathogen, but merely 
a contaminant [14]. However, our patient was at risk (severe 
sepsis with intestinal obstruction) for C. tertium bacteremia, and 
C. tertium was isolated from all three blood cultures. Thus, C. 
tertium bacteremia, in this case, was not likely a result of culture 
contamination.
Clostridium tertium is not histotoxic, lipolytic, or toxin-pro-
ducing. When C. tertium bacteremia is treated with appropriate 
antimicrobial therapies, the mortality rate is quite low [1].  In several 
studies, most patients with C. tertium bacteremia survived after 
appropriate antibiotic therapy [2, 3]. In this case, C. tertium did not 
grow in the blood cultures after the administration of tigecycline. 
The patient’s cause of death was classified as multi-organ failure 
and acute respiratory distress syndrome due to post-operative 
bleeding. 
Clostridium tertium is resistant to many beta-lactams, and it 
is often resistant to expanded-spectrum cephalosporins with 
enhanced activity against gram-positive bacteria [7]. A penicillin-
resistant strain has also been reported [10]. Metronidazole, which 
is commonly used to treat anaerobic infections, may be effective 
[6, 10], but resistant C. tertium isolates have been described [11]. In 
vitro, tigecycline has been shown to have potent inhibitory activity 
against C. tertium [15].
Tigecycline was used to successfully treat patients with 
complicated intra-abdominal infections in several studies [16, 
17]. Tigecycline is not significantly toxic and has a wide spectrum 
Figure 3. Morphology of Gram-stained Clostridium tertium on blood agar plates 
incubated aerobically (A) and anaerobically (B) (X1,000). A stained smear from 
an anaerobic blood agar plate shows occasional Gram-positive bacilli with oval 
terminal spores (black arrows) (X1,000).
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of antibiotic activities. We applied tigecycline as an alternative 
antimicrobial. 
In conclusion, we describe a case of C. tertium bacteremia 
in a non-neutropenic patient with small bowel obstruction. 
Clostridium tertium rarely causes bacteremia in non-neutropenic 
patients. However, pre-existing intestinal mucosal injury increases 
susceptibility to C. tertium bacteremia. Furthermore, because of 
the aerotolerant nature of the isolate, Clostridium species were 
not initially considered, resulting in delayed identification and 
reporting. 
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